Torrent Pharmaceuticals
BSE: 500420 | NSE: TORNTPHARM | ISIN: INE685A01028 | SECTOR: Biotechnology & DrugsOpen
2,649.95High
2,698.95Low
2,649.45Prev Close
2,636.30P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
912.64BVolume
4.23KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
2,693.05Ask
2,696.55
Company Description
- Biotechnology & Drugs
BSE
500420NSE
TORNTPHARMISIN
INE685A01028
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Company Officers
Samir Mehta
Executive Chairman of the BoardSudhir Menon
Chief Financial Officer, Executive Director - FinanceChintan Trivedi
Compliance Officer, Company SecretaryAman Mehta
Executive DirectorJinesh Shah
Whole-Time Director, Director - Operations